10 Things Worth Pay...
Health Care: Drugs
ACADIA Pharmaceuticals Inc. (ACAD: NASDAQ)
$1.33 0.02 | 1.53%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -22.76M | 15.14M | -45.14M | -64.24M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -29.00K | -990.00K | 656.00K | -276.00K |
| (Decrease) Increase In Other Current Liabilities | 277.00K | -2.14M | -2.28M | -7.08M |
| (Increase) Decrease In Other Working Capital | -43.00K | -25.37M | 28.20M | -186.00K |
| Other Non-Cash Items | 2.40M | 1.37M | 2.72M | 2.99M |
| Net Cash From Continuing Operations | -19.90M | -10.70M | -13.73M | -64.87M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -19.90M | -10.70M | -13.73M | -64.87M |
| Sale of Property, Plant & Equipment | 0.00 | 128.00K | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 54.05M | 53.49M | 59.75M | 149.91M |
| Purchases of Property, Plant & Equipment | 0.00 | 0.00 | -41.00K | -226.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -48.07M | -54.67M | -50.26M | -79.97M |
| Other Cash from Investing Activities | -3.00K | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 5.98M | -1.06M | 9.44M | 69.71M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 14.02M | 823.00K | 1.92M | 535.00K |
| Repayment of Long-Term Debt | -78.00K | -353.00K | -762.00K | -909.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 13.94M | 470.00K | 1.16M | -374.00K |
| Effect of Exchange Rate Changes | 13.00K | 20.00K | 73.00K | -287.00K |
| Net Change in Cash & Cash Equivalents | 40.00K | -11.27M | -3.05M | 4.18M |
Portfolios with ACAD
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserBerliner
- Contributor5 Stocks Under-$10 Setting ...
- Contributor10 Pharma Stocks Under $3
- Userazfar
- UserMy Portfolio
- UserNUKE PORTFOLIO
Latest ACAD Headlines from TheStreet
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- ACADIA Stock Gaps Down On Today's Open (ACAD) 04.26.12 | 09:04 am
- ACADIA Pharmaceuticals Inc. Stock Downgraded (ACAD) 04.11.12 | 05:04 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- ACADIA Stock Soars (ACAD) 03.13.12 | 03:03 pm
- 5 Stocks Under $5 Making Big Moves 03.13.12 | 02:03 pm
- ACADIA Stock Soars (ACAD) 01.18.12 | 04:01 pm
- 7 Stocks Under $10 Ripping Higher 12.20.11 | 02:12 pm
- Acadia Pharmaceuticals: Investing With No Safety Net 06.24.11 | 10:06 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
Press Releases for ACAD
- ACADIA Pharmaceuticals To Webcast Educational Program On Parkinson’s Disease Psychosis On May 22, 2012 - Business Wire 05.15.12 | 09:05 am
- ACADIA Pharmaceuticals Reports First Quarter 2012 Financial Results - Business Wire 05.08.12 | 04:05 pm
- ACADIA Pharmaceuticals To Present At The 19th Annual Future Leaders In The Biotech Industry Conference On April 20, 2012 - Business Wire 04.13.12 | 09:04 am
- ACADIA Pharmaceuticals To Present At The 11th Annual Needham Healthcare Conference On April 3, 2012 - Business Wire 03.28.12 | 09:03 am
- ACADIA Pharmaceuticals Awarded New Grant From The Michael J. Fox Foundation For Development Of Nurr1-RXR Selective Agonists To Treat Parkinson’s Disease - Business Wire 03.27.12 | 09:03 am
- ACADIA Pharmaceuticals Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2011 - Business Wire 03.06.12 | 04:03 pm
- ACADIA Pharmaceuticals Announces Extension Of Drug Discovery Collaboration With Allergan, Inc. - Business Wire 03.05.12 | 09:03 am
- ACADIA Pharmaceuticals To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 09:02 am
- ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2011 Financial Results On March 6, 2012 - Business Wire 02.28.12 | 09:02 am
- ACADIA Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 13, 2012 - Business Wire 02.06.12 | 09:02 am
Partner Headlines for ACAD
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- 7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows - Seeking Alpha 02.03.12 | 07:02 pm
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.25.12 | 09:01 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 01.23.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.19.12 | 09:01 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 01.17.12 | 09:01 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.13.12 | 09:01 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
